✦ LIBER ✦

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

✍ Scribed by Bernd Kronenberger; Eva Herrmann; Florence Micol; Michael von Wagner; Stefan Zeuzem

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 187 KB
Volume: 40
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.20487

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Viral kinetics during antiviral therapy

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

✍ Claudio Puoti; Lia Bellis; Roberto Castellacci; Fabrizio Montagnese 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

We read with interest a paper by Kudo et al. published in a recent issue of HEPATOLOGY that compared the predictive power between Japan Integrated Staging (JIS) system and Cancer of the Liver Italian Program (CLIP) system in a large patient cohort with hepatocellular carcinoma (HCC). 1 The authors c

Increased frequency of HLA DR13 in hepat

Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels

✍ Kuzushita, Noriyoshi; Hayashi, Norio; Katayama, Kazuhiro; Hiramatsu, Naoki; Yasu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 872 KB

HLA DR13 may be closely associated with this low activity of hepatitis among HCV carriers.

Genetic variability of hepatitis C virus

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon–ribavirin therapy

✍ I. Vuillermoz; E. Khattab; E. Sablon; I. Ottevaere; D. Durantel; C. Vieux; C. Tr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

## Abstract Little is known about hepatitis C virus (HCV) breakthrough during antiviral therapy, although it would help in understanding HCV resistance to current antiviral treatments. To analyse the implication of virological factors and the vigour of humoral immune responses in this phenomenon, w

Hepatitis C virus RNA kinetics in chimer

Hepatitis C virus RNA kinetics in chimeric mice with human hepatocytes during antiviral therapy

✍ Kazuaki Inoue; Tsunamasa Watanabe; Makoto Yoshiba; Michinori Kohara 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

Clinical features of hepatitis C–infecte

Clinical features of hepatitis C–infected patients with persistently normal alanine transaminase levels in the southwestern United States

✍ M. Mazen Jamal; Anurag Soni; Patrick G. Quinn; Donald E. Wheeler; Sanjeev Arora; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

Approximately one third of patients with chronic hepatitis C virus (HCV) infection have normal alanine transaminase (ALT) levels. We studied the clinical, biochemical, virological, and histological features in patients with persistently normal ALT. A case-control study was conducted on 275 patients

Prediction of response during interferon

Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison

✍ M J Tong; L M Blatt; J G McHutchison; R L Co; A Conrad 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

Patients with chronic hepatitis C (n Å 103) were treated cases of acute hepatitis C occur on an annual basis, and an estimated 8,000 to 10,000 deaths occur each year of compli-for 24 weeks with interferon alfa 2b and followed up for 24 weeks after cessation of therapy (week 48). When hepatitis catio